Medical-process patents - Monopolizing the delivery of health care

New England Journal of Medicine

Volumn 355, Issue 19, 2006, Pages 2036-2041

  Kesselheim, Aaron S ^a   Mello, Michelle M ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL PRACTICE; MEDICAL SCHOOL; MEDICAL SOCIETY; PATENT; PHYSICIAN; PRIORITY JOURNAL;

DELIVERY OF HEALTH CARE; HISTORY, 20TH CENTURY; HUMANS; INTELLECTUAL PROPERTY; LABORATORY TECHNIQUES AND PROCEDURES; LEGISLATION, MEDICAL; PATENTS; SUPREME COURT DECISIONS; UNITED STATES;

EID: 33750708526     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMhpr063626     Document Type: Article

References (35)

1. Kesselheim AS, Avorn J. University-based science and biotechnology products: defining the boundaries of intellectual property. JAMA 2005;293:850-4.
2. Resnik DB. Are DNA patents bad for medicine? Health Policy 2003;65:181-97.
3. Andrews LB. Genes and patent policy: rethinking intellectual property rights. Nat Rev Genet 2002;3:803-8.
4. American Medical Association, Council on Ethical and Judicial Affairs. Code of Medical Ethics, Opinion E-9.095. (Accessed October 19, 2006, at http://www.ama-assn.org/ad-com/polfind/hlth-ethics.pdf.)
5. Mitnovetski O, Nicol D. Are patents for methods of medical treatment contrary to the ordre public and morality or "generally inconvenient"? J Med Ethics 2004;30:470-5.
6. European Patent Convention. Article 52(4) (1973). (Accessed October 19, 2006, at http://www.european-patent-office.org/legal/epc/e/ar52.html#A52.)
7. 35 U.S.C. § 287(c) (1996).
8. 35 U.S.C. § 101 (2005).
9. 447 U.S. 303 (1980).
10. 470 U.S. 175 (1981).
11. McCormick B. Just reward or just plain wrong? Specter of royalties from method patents stirs debate. American Medical News. September 5, 1994:3.
12. U.S. Patent No. 6,770,279 (Aug. 3, 2004).
13. Pallin v. Singer, 36 U.S.P.Q. 2d 1050 (D. Vt. 1995).
14. Ethical issues in the patenting of medical procedures. Food Drug Law J 1998;53:341-51.
15. Medical Procedures and Innovation Affordability Act, H.R. 1127, 104th Cong., 1st Sess. (1995).
16. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 1988;81:466-74.
17. U.S. Patent No. 4,940,658 (July 10, 1990).
18. Metabolite Laboratories v. Laboratory Corporation of America, 370 F.3d 1354, 1367 (F.C.C.A. 2005).
19. Laboratory Corporation of America v. Metabolite Laboratories, 126 S. Ct. 601 (2005).
20. Brief for Petitioner, Laboratory Corporation of America v. Metabolite Laboratories, No. 04-607 (2005).
21. Gottschalk v. Benson, 409 U.S. 63 (1972).
22. State Street Bank & Trust Co. v. Signature Financial Group, 149 F.3d 1368, 1373 (F.C.C.A. 1998).
23. Eisenberg RS. Patent swords and shields. Science 2003;299:1018-9.
24. Burk DL, Lemley MA. Policy levers in patent law. Va Law Rev 2003;89:1575-696.
25. Jaffe AB, Lerner J. Innovation and its discontents. Princeton, NJ: Princeton University Press, 2004.
26. Laboratory Corporation of America v. Metabolite Laboratories, 126 S. Ct. 2921 (2006).
27. Kesselheim AS, Fischer MA, Avorn J. Extensions of intellectual property rights and delayed adoption of generic drugs: effects on Medicaid expenditures. Health Aff (Millwood) (in press).
28. Zimmerman R, Rodgers S. FDA backs marketing of generic version of AstraZeneca's Prilosec by Andrx Corp. Wall Street Journal. November 19, 2001.
29. Blumenthal D, Campbell EG, Anderson MS, Causino N, Louis KS. Withholding research results in academic life science: evidence from a national survey of faculty. JAMA 1997;277:1224-8.
30. Metabolite Laboratories v. Laboratory Corporation of America, 370 F.3d 1354, 1364 (F.C.C.A. 2005).
31. Brief of Patients Not Patents, Inc. as amicus curiae in support of Petitioner, Laboratory Corporation of America v. Metabolite Laboratories, No. 04-067 (Dec. 23, 2005).
32. U.S. Patent No. 6,469,012 (Oct. 22, 2002).
33. Pfizer sues over Viagra patent. Intellectual Property Litigation Reporter. November 12, 2002.
34. U.S. Patent No. 5,279,949 (Jan. 18, 1994).
35. U.S. Patent No. 4,848 (Nov. 12, 1846).